Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Fareston launched in U.S. for metastatic breast cancer

Dec. 4, 1997

Agouron, Roche terminate cancer collaboration; AG-337 development discontinued

Dec. 4, 1997

MDR modulators prepared at Janssen

Dec. 4, 1997

Single injections of RC-3095 produce prolonged reductions in EGF receptor number and expression

Dec. 4, 1997

Miravant reports promising interim phase III results for breast cancer trial

Dec. 4, 1997

Pfizer discontinues collaboration with Megabios

Dec. 3, 1997

VEGF receptor tyrosine kinase inhibitors under development at Zeneca

Dec. 3, 1997

Water-soluble taxanes reported in patent literature

Dec. 3, 1997

EntreMed reports positive preclinical results using Endostatin

Dec. 3, 1997

ALVAC-IL-12 gene therapy effective in murine model of breast cancer

Dec. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...